A vaccine again available for seniors, here are the figures in France

The number of Aboriginal cases of Chikungunya continues to increase in France. Consequently, In his latest assessment published on July 9. However, Public Health France brought together 25 Aboriginal cases in mainland France, compared to 15 a week earlier. Nevertheless, Several cases have indeed been detected in recent days. Nevertheless, including one case in Corsica reported this July 10 by the Regional Health Agency. Additionally, Nevertheless, This is the fourth Aboriginal case (all in Corse-du-Sud). In addition,

Also. Furthermore, the Regional vaccine again available seniors, here Health Agency (ARS) Provence-Alpes-Côte d’Azur announced on July 8 that 12 indigenous cases had been detected in the Bouches-du-Rhône, 7 more since the France Public Health Review. Similarly, 10 cases were “located in the same district of Salon-de-Provence. For example, the other 2 resident in the town of Grans and that of Lambesc” according to ARS.

Other regions have also recently announced new cases. Meanwhile, In Auvergne-Rhône-Alpes, an indigenous case was confirmed on July 8 according to the Regional Health Agency. However, It was more precisely detected in Claix, in Isère. In Nouvelle-Aquitainef (in Illats), a case in a child was announced on July 2.

Where were the previous Aboriginal cases detected this year? – Vaccine again available seniors, here

All other indigenous cases have been detected since June in these regions: Provence-Alpes-Côte-d’Azur. Corsica, Occitanie, Nouvelle-Aquitaine, Auvergne-Rhône-Alpes and Grand-Est. The cases were more precisely detected:

&#13.
• in Hérault in Prades-le-Lez,
• In the Var at vaccine again available seniors, here La Crau (2 cases),
• In the Bouches-du-Rhône at Salon de Provence (10 cases), Grans and Lambesc,
• Best Sout in Grosseto Sud in Plumgues (3 Cav),
• in Drôme in Montoison (3 cases),
• in the Gard in Bernis,
• In the Bas-Rhin in Lipshein,
• in Illats, in New Aquitaine,
• In Isère, in Claix.

“Telle precocity in the activity season of the mosquito. such a high number of episodes had never been observed so far,” said Public Santé France in its latest assessment. Since the beginning of 2025. nearly 1,700 cases of Chikungunya (imported and indigenous) have been detected in metropolitan France, including 761 only between May 1 and July 7 according to the latest public health report France. The three most affected regions are: Auvergne-Rhône-Alpes, Ile-de-France and Nouvelle-Aquitaine. The previous two years, only thirty cases had been declared, including 0 or vaccine again available seniors, here 1 Aboriginal case (contracted in the territory).

What are the latest figures for the epidemic in Reunion and Mayotte?

Chikungunya’s epidemic ends in Reunion but started in Mayotte. Furthermore, The territory passed in the epidemic phase on May 27, 2025, according to public health France. The institute indicates that “the circulation of chikungunya remains active with high intensity” in Mayotte. Nearly 1,000 cases have so far been detected, and no death has been reported.

In Reunion, a drop in epidemic indicators has been observed since the end of April. The epidemic is now “of low intensity”. even if the virus still circulates there and that “cases are still confirmed” according to the latest public health report France published on June 18. Nearly 54,000 cases have been declared on the island since the start of the year. The chikungunya epidemic caused the death of 27 people in total, who were “essentially” vaccine again available seniors, here over 65 years and comorbidities.

How to protect yourself from chikungunya?

Several vaccines against chikungunya exist. Until then, it was not recommended for travelers to be vaccinated against chikungunya. But in its 2025 recommendations to travelers, the High Public Health Council updated the recommendations concerning Chikungunya.

A new vaccine authorized in Europe in February 2025 then arrived in June in France. called Vimkunya, is now recommended in the event of a stay “in an area where an epidemic is proven”, “in the event of a prolonged stay” or “repeated stays in an area where active circulation of the virus” is observed, among 12-65 years who have comorbidities. Vaccination is only “to consider” among those over 65 and 12-65 year olds who have no comorbidities. It is not currently recommended for pregnant and lactating women for the moment, due to lack of sufficient data.

Another vaccine, Ixchiq, was already available but vaccine again available seniors, here it is not recommended for travelers. It is only “to consider” in 12-65 year olds who are not immunocompromised. The European Medicines Agency announced on July 11 that it was again authorized among those over 65 after being. against contraindicated in this age group. Several serious undesirable effects – including 3 deaths – had indeed been identified during the vaccination campaign set up in the meeting in early April. according to the National Agency for the Safety of Medicines.

Apart from vaccination. the only way to protect yourself from the disease is to avoid being bitten by mosquitoes thanks to repellents, mosquito nets and wearing long and ample clothes. It is recommended to monitor a possible appearance of symptoms to people who live. go or come back from the meeting.

Fragile people should be particularly vigilant. especially those suffering from chronic diseases, but also pregnant women and immunocompromised people, and vaccine again available seniors, here now those over 65, in whom vaccination is not recommended. The disease can indeed be serious in these people. Today there is no specific treatment against chikungunya. The only available treatments are symptomatic, including paracetamol. Part of the population is already immune to chikungunya following the last epidemic in 2005-2006, which had affected around 260,000 people.